gp 531 has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hale, SL; Kloner, RA | 1 |
| Buggé, CJ; Bullough, DA; Kurz, MA; Mullane, KM; Young, MA | 1 |
2 other study(ies) available for gp 531 and Heart Disease, Ischemic
| Article | Year |
|---|---|
Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit.
Topics: Adenosine; Aminoimidazole Carboxamide; Analysis of Variance; Animals; Deoxyribonucleosides; Disease Models, Animal; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rabbits; Random Allocation | 2010 |
Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Cardiotonic Agents; Deoxyribonucleosides; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Swine; Swine, Miniature | 1997 |